Immobilization-Related Hypercalcemia in a COVID-19 Patient With Prolonged Intensive Care Unit Stay.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 34657087.
- Also identified by DOI 10.1097/PHM.0000000000001907 and PMC identifier 8667683.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Immobilization-related hypercalcemia is an uncommon finding in patients admitted to intensive care unit. We report a case of severe hypercalcemia in a COVID-19 patient admitted to intensive care unit for hypoxemic respiratory failure. He developed an acute kidney injury requiring continuous renal replacement therapy with regional citrate anticoagulation. Citrate chelates ionized calcium and stop the coagulation cascade locally, preventing filter clotting. Calcium is then given intravenously to a specific target (normocalcemia). It is only when calcium infusion has been stopped that bone resorption and hypercalcemia were unmasked.
Medical subject headings
- Acute Kidney Injury
- COVID-19
- Hypercalcemia
- Immobilization
- Intensive Care Units
- Respiratory Insufficiency